News

CARsgen Therapeutics Holdings Limited and Huadong Medicine announced a collaboration for the commercialization of CARsgen's BCMA CAR-T product CT053 in mainland China. CT053,…
Read More...

Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company, announced that the China National Medical Products Administration (NMPA) has approved BAT1806, a biosimilar of…
Read More...

Roche announced that the European Commission (EC) has approved Xofluza (baloxavir marboxil) in children aged one year and above for the treatment of uncomplicated influenza and for…
Read More...

The Sabin Vaccine Institute announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to…
Read More...

AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) for self-administration in…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered an option and research collaboration agreement with Monash University (Melbourne, Victoria, Australia) to discover and develop…
Read More...

Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, announced that the U.S. Food and…
Read More...

Daiichi Sankyo announced the submission of an application for marketing approval of DS-5670 to the regulatory authorities in Japan. DS-5670 is an mRNA vaccine, being developed against…
Read More...

Takeda announced that EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced…
Read More...

On January 6, 2023, Health Canada approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast…
Read More...

Catalent, the global leader in enabling the development and supply of better treatments across multiple modalities, and Ethicann Pharmaceuticals Inc., a Canadian/U.S. specialty…
Read More...

Myrtelle Inc., a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, and rAAVen Therapeutics, (“rAAVen”) an AAV…
Read More...

Merck, known as MSD outside of the United States and Canada, announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of…
Read More...

PreveCeutical Medical Inc. is pleased to announce that it has entered into a License Option Agreement with Endosane Pharmaceuticals GmbH (“Endosane”), a subsidiary of Sanity Group,…
Read More...

Solid Biosciences Inc. and Phlox Therapeutics announced a strategic collaboration focused on genetic cardiac diseases. The research collaboration will target a severe form of genetic…
Read More...

Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory approval, announces that…
Read More...

Syneos Health announced a strategic partnership with Fosun Pharma USA Inc., the US-based subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. As part of the partnership, Syneos…
Read More...

AbbVie and Anima Biotech announced a collaboration to discover and develop mRNA biology modulators for three targets across Oncology and Immunology. Anima will use its mRNA Lightning…
Read More...

UNION therapeutics A/S (UNION), a privately-held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, announced that the US…
Read More...

BioNTech SE and InstaDeep Ltd. announced that they have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field of…
Read More...